Minerva Neurosciences (NERV) Current Leases (2019 - 2021)
Minerva Neurosciences' (NERV) quarterly Current Leases came in at $16288.0 in Q2 2021, down 91.19% YoY from $184777.0 in Q2 2020, and down 74.69% on a QoQ basis from $64350.0 in Q1 2021.
Analysis
Minerva Neurosciences (NERV) Current Leases (2019 - 2021) Analysis & Trends
Minerva Neurosciences (NERV) has 3 years of Current Leases data on file, last reported at $16288.0 in Q2 2021.
- Quarterly Current Leases fell 91.19% year-over-year to $16288.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $16288.0 (down 91.19% YoY) and the FY2020 annual result came in at $111229.0, down 35.67% from the prior year.
- Current Leases eased to $16288.0 in Q2 2021, from $64350.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $184777.0 in Q2 2020 to a low of $16288.0 in Q2 2021.
- A 3-year average of $137020.8 and a median of $159279.0 in 2019 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2020 — Current Leases gained 14.48% — and 2021, when it sank 91.19%.
- Tracing NERV's Current Leases over 3 years: stood at $172901.0 in 2019, then slumped by 35.67% to $111229.0 in 2020, then plunged by 85.36% to $16288.0 in 2021.
- The last three Current Leases figures came in at $16288.0 (Q2 2021), $64350.0 (Q1 2021), and $111229.0 (Q4 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 11.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 16.75 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 21.95 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Minerva Neurosciences | 207.37 Mn | 207.37 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 16,288.00 |
| Mar 31, 2021 | 64,350.00 |
| Dec 31, 2020 | 111,229.00 |
| Sep 30, 2020 | 156,956.00 |
| Jun 30, 2020 | 184,777.00 |
| Mar 31, 2020 | 178,765.00 |
| Dec 31, 2019 | 172,901.00 |
| Sep 30, 2019 | 167,181.00 |
| Jun 30, 2019 | 161,602.00 |
| Mar 31, 2019 | 156,159.00 |